ELISA/assay

Bovine Vascular endothelial growth factor A ELISA Kit

MBS2887434

48-Strip-Wells

305 USD

ELISA Kit

Bovine Vascular endothelial growth factor A ELISA Kit

[Vascular endothelial growth factor A]

[Vascular endothelial growth factor A; VEGF-A; Vascular permeability factor; VPF; VEGFA; VEGF]

[vascular endothelial growth factor A isoform VEGF-A; Vascular endothelial growth factor A; vascular endothelial growth factor A; Vascular permeability factor; VPF]

[VEGFA]

[VEGFA; VEGFA; VPF; VEGF; VEGF-A; eVEGF120; eVEGF164; VEGF; VEGF-A; VPF]

VEGFA_BOVIN

Bovine

190

For long term storage, please store the entire kit at -20 degree C.

Typical Testing Data/Standard Curve (for reference only)

Samples: Serum, Plasma, Tissue Homogenates, Cell Culture Supernates Or Other Biological Fluids.

Intended Uses: This immunoassay kit allows for the in vitro quantitative determination of target antigen concentrations in serum, plasma, tissue homogenates, cell culture supernates or other biological fluids. Principle of the Assay: The microtiter plate provided in this kit has been pre-coated with an antibody specific to target antigen. Standards or samples are then added to the appropriate microtiter plate wells with a biotin-conjugated antibody preparation specific for target antigen and then avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. Then a TMB substrate solution is added to each well. Only those wells that contain target antigen, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of a sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450 nm +/- 2 nm. The concentration of target antigen in the samples is then determined by comparing the O.D. of the samples to the standard curve.

27806357

NP_776641.1

NM_174216.2

P15691

17,086 Da

AGE-RAGE Signaling Pathway In Diabetic Complications (1319849); AGE-RAGE Signaling Pathway In Diabetic Complications (1319775); Bladder Cancer Pathway (84350); Bladder Cancer Pathway (527); Cytokine-cytokine Receptor Interaction Pathway (84290); Cytokine-cytokine Receptor Interaction Pathway (460); Endochondral Ossification Pathway (920938); Focal Adhesion Pathway (84306); Focal Adhesion Pathway (478); HIF-1 Signaling Pathway (695207)

This gene is a member of the PDGF/VEGF growth factor family. It encodes a heparin-binding protein, which exists as a disulfide-linked homodimer. This growth factor induces proliferation and migration of vascular endothelial cells, and is essential for both physiological and pathological angiogenesis. It is upregulated in many known tumors and its expression is correlated with tumor stage and progression. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. A recent study showed that a C-terminally extended isoform is produced by use of an alternative in-frame translation termination codon via a stop codon readthrough mechanism, and that this isoform is antiangiogenic. [provided by RefSeq, Nov 2015]

Growth factor active in angiogenesis, vasculogenesis and endothelial cell growth. Induces endothelial cell proliferation, promotes cell migration, inhibits apoptosis and induces permeabilization of blood vessels. Binds to the FLT1/VEGFR1 and KDR/VEGFR2 receptors, heparan sulfate and heparin ().

48-Strip-Wells

305 USD

96-Strip-Wells

395

5x96-Strip-Wells

1615

10x96-Strip-Wells

2880